- Home
- MCI vs CYRX Comparison
MCI vs CYRX Comparison
Compare MCI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCI | CYRX |
|---|---|---|
| Founded | 1971 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 421.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | MCI | CYRX |
|---|---|---|
| Price | $20.35 | $8.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 19.3K | ★ 341.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 8.46% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 1.82 | 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | $11.29 | ★ $4.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.00 | $4.63 |
| 52 Week High | $23.79 | $11.45 |
Technical Indicators
Market Signals| Indicator | MCI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 37.26 |
| Support Level | $19.98 | $6.57 |
| Resistance Level | $21.14 | $8.45 |
| Average True Range (ATR) | 0.33 | 0.51 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 38.32 | 25.71 |
Price Performance
Historical ComparisonAbout MCI Barings Corporate Investors
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.